1. | schachererjm | |
2. | kungfuninjaninja | |
3. | juliomuneca476 | |
4. | cwhitebiz | |
5. | 296brenda44 |
1. | schachererjm | |
2. | kungfuninjaninja | |
3. | juliomuneca476 | |
4. | cwhitebiz | |
5. | 296brenda44 |
1. | kungfuninjaninja 05/06/2018 Anyone? |
2. | juliomuneca476 05/18/2018 Positive drug update for ADVM-022 macular degeneration treatment |
3. | cwhitebiz 08/27/2018 Adverum Biotechnologies Receives Orphan Drug Designation for ADVM-053, a Novel Gene Therapy Candidate for the Treatment of Hereditary Angioedema |
4. | kungfuninjaninja 05/01/2018 Adverum Biotechnologies Announces Long-term Preclinical Efficacy Data on ADVM-022 Gene Therapy in Wet AMD |
5. | schachererjm 02/15/2018 I have never even heard of these guys |
6. | kungfuninjaninja 08/09/2018 Reports Q2 EPS loss of $0.30 and revenue of $0.49M (+6.5% Y/Y) |
7. | schachererjm 02/12/2018 Adverum Biotechnologies Announces Closing of $69 Million Public Offering |
8. | schachererjm 02/07/2018 Commenced an underwritten public offering of its common stock |